What is an STI (STD) Test Panel?
An STI test panel is a group of lab tests ordered together to screen for multiple sexually transmitted infections (STIs) at the same time. Most panels use a combination of a blood sample and a urine sample, allowing for comprehensive STI screening in a single visit.
The terms “STD” and “STI” are often used interchangeably. A Sexually Transmitted Infection (STI) occurs when a virus, bacterium, fungus, or parasite infects a person, yet no symptoms are evident. A Sexually Transmitted Disease (STD) means that the infection has evolved into demonstrable symptoms. Though STD screening and STI screening refer to the same battery of tests performed, the preferred, current terminology used is STI. A typical STI screening combines blood tests used to detect infections such as HIV, hepatitis, syphilis, and herpes with urine-based tests or swabs of the affected areas, for infections like chlamydia and gonorrhea. Overall, there are over 30 different pathogens that can be transmitted through oral, vaginal, or anal sex.
No single test can screen for every STI. Instead, an STI panel is designed to cover the most common and clinically significant conditions based on screening recommendations from the CDC.
What’s Included in a 4-Panel, 7-Panel, 10-Panel, and 13-Panel STI Test
STD (STI) test panels are available in several sizes, each designed to screen for a different range of infections. The right option depends on factors such as risk level, symptoms, and how long it has been since your last test. The table below compares common panel types, from basic screening to a full panel STI test.
| Panel Size | What’s Tested | Who It’s Recommended For |
| 4-Panel (Basic) | Chlamydia, gonorrhea, syphilis, HIV | CDC baseline screening for sexually active adults |
| 7-Panel (Standard) | Chlamydia, gonorrhea, syphilis, HIV, hepatitis B, hepatitis C, trichomoniasis | People with multiple partners or those who have not been tested in over a year |
| 10-Panel (Full) | Chlamydia, gonorrhea, syphilis, HIV, hepatitis A, hepatitis B, hepatitis C, herpes 1, herpes 2, trichomoniasis | Individuals seeking broader screening or a more comprehensive 10 panel STD test |
| 13-Panel (Extended) | Chlamydia, gonorrhea, syphilis, HIV 1 & 2, hepatitis A, hepatitis B, hepatitis C, herpes 1, herpes 2, trichomoniasis, mycoplasma genitalium, plus additional wellness markers may be done (e.g., CBC, liver function panel, thyroid panel, metabolic panel) | Those who want the most complete STD panel available or expanded screening |
Panel names and sizes can vary by lab, and not every provider uses the same terminology. The number in the panel name refers to how many infections are included in the screening and not how many samples are collected. Most panels still require only a blood sample and a urine sample, even when testing for multiple infections.
What Each Test in the Panel Screens For
If you find yourself asking what does a full STI panel test for, most panels are designed to detect a core group of common infections using a combination of blood and urine testing. These infections can affect the reproductive system, immune system, or liver, with many not causing symptoms in the early stages.
- Chlamydia: A common bacterial infection often detected using a urine sample or a swab of the throat, genital, or rectum areas. If untreated, it can lead to pelvic inflammatory disease, pregnancy complications, and infertility. With women, pelvic inflammatory disease (PID) may be seen, causing swelling and scarring of the uterus, fallopian tubes, and ovaries
- Gonorrhea: A bacterial infection that can affect the genitals, throat, or rectum. It is detected through urine testing and without treatment, can cause long-term reproductive complications for both men and women.
- Syphilis: A bacterial infection identified through a blood test. If untreated, it can progress through 3 stages that, if left untreated, can cause serious damage to the brain, nerves, and heart, and even death.
- HIV 1 & 2: A viral infection that attacks the immune system and is detected through blood testing. Without treatment, it can lead to acquired immunodeficiency syndrome (AIDS). With or without AIDS, there is a significant risk of developing cancers such as Kaposi sarcoma, non-Hodgkin lymphoma, cervical cancer, and lung cancer.
- Herpes 1 & 2 (HSV): Viral infections that cause lifelong outbreaks of painful blisters and are typically identified through blood tests. While not curable, symptoms can be managed and can clear on their own. If left untreated, open lesions can make it easier for other STIs to invade. In severe cases, HSV can evolve to encephalitis or meningitis, or be passed on to babies at birth, and can cause severe skin and eye infections.
- Hepatitis A, B, and C: Viral infections that affect the liver and are detected through blood testing. Some forms resolve on their own, while others can become chronic and lead to liver damage (cirrhosis), and in severe cases, lead to liver cancer.
- Trichomoniasis: A parasitic infection detected through urine testing that may cause irritation or discharge. If untreated, it can increase the risk of other STIs, especially HIV. Infected pregnant women may deliver prematurely, resulting in low birth weights (<5.5 lbs.).
- Mycoplasma genitalium (Mgen): A bacterial infection of the cervix, inside the penis, or the rectum, which is detected through specialized urine testing. Without treatment, it may lead to ongoing inflammation and cause PID, infertility, ectopic pregnancy, or preterm births.
- Human Papillomavirus (HPV): A virus that can cause genital warts. In some cases, there is an increased risk of cancer, including the cervix, throat, vulva, vagina, anus, or penis.
Blood-Based STD Tests
Blood-based tests are used to detect infections that circulate in the bloodstream or trigger an immune response. A standard STI blood test screens for HIV, syphilis, hepatitis A, B, and C, and herpes 1 and 2, though panels can vary by laboratory. HIV is typically detected using a 4th generation antigen/antibody test, while syphilis is screened using a rapid plasma reagin (RPR) test. Hepatitis infections are identified through antibody or antigen testing, and herpes 1 and 2 are detected using IgG antibody testing.
Antibody tests detect your body’s immune response to an infection (immune system proteins), while antigen tests detect parts of the virus (viral proteins) itself. Because these tests rely on either viral presence or immune response, blood-based STD tests may take longer to become accurate after exposure. Depending on the infection, this window period can range from a few days to 16 weeks after initial exposure from unprotected sex.
Urine-Based STD (STI) Tests
Urine-based tests are used to detect infections in the urinary and reproductive tracts, including chlamydia and gonorrhea testing, trichomoniasis testing, and mycoplasma genitalium. A standard STI urine test uses a first-catch urine sample that contains the highest concentration of the pathogen. It is then tested using a method called nucleic acid amplification testing (NAAT), which detects the genetic material of the organism and is considered the most accurate testing method available.
In some cases, labs may also use a urine culture to identify certain bacteria, although NAAT is the primary method used for STD screening.
Urine collection is simple and non-invasive, requiring only a small sample. Testing accuracy is particularly high in males because the pathogens tend to reside in the urethra, whereas in females, testing accuracy may be slightly less due to infections mainly residing in the cervix. A vaginal swab may also be needed.
When to Get Tested: STI Window Periods
Knowing when to get tested for STI) infections is just as important as the test itself. Each infection has a different STD window period, which is the time between exposure and when a test can reliably detect it. Testing too early may result in a false negative, meaning the test shows no infection even if one is present.
The table below shows when common infections can be detected and when testing is most reliable:
| Infection | Earliest Accurate Test | Notes |
| Chlamydia/Gonorrhea | Chlamydia:1 to 2 weeks
Gonorrhea: 5 days-2 weeks |
Blood, urine, swab |
| HIV | 10-33 days (NAT)18-45 days (antigen antibody test) | Blood, saliva |
| Herpes | 4-16 weeks | Blood, swab |
| Syphilis | 3 to 6 weeks | Sores appear 1 week after exposure; blood test |
| Herpes (IgG antibody) | 4-16 weeks | Blood, swab |
| Hepatitis B | 3 to 6 weeks | Blood test |
| Hepatitis C | 2-6 weeks | Blood test |
| Human Papilloma Virus (HPV) | 3 weeks to several months | Pap smear for women
Males, no test available; diagnosis based on symptoms (genital warts) |
| Mycoplasma genitalium (Mgen) | 1-3 weeks after exposure | Test method: NAT
Generally no symptoms |
Because window periods vary, a single test may not detect every infection right away. For the most reliable results across a full panel, the CDC recommends waiting at least three weeks after potential exposure before testing and to consider repeat testing at three months. For more detailed timing guidance, see our guide on how long to wait before testing for STDs.
Who Should Get an STI Panel?
STI screening is recommended for a wide range of people, even if there are no symptoms. So, who should get tested? The CDC provides clear guidance based on age, sexual activity, and risk factors:
- All adults ages 13 to 64: The CDC recommends at least one lifetime HIV test as part of routine health care.
- Sexually active women under 25: Annual screening for chlamydia and gonorrhea is recommended due to higher rates of infection in this group.
- Men who have sex with men: The CDC recommends full STI screening at least once a year, or every 3 to 6 months for those with multiple partners.
- Pregnant individuals: Testing for HIV, syphilis, and hepatitis B is recommended at the first prenatal visit. Chlamydia screening is also recommended for those under 25 or at increased risk.
- Anyone with a new or multiple sexual partners: Regular STI screening is recommended to reduce the risk of undiagnosed infections.
- Anyone who has had unprotected sex: Testing is recommended to check for potential exposure to STIs.
- People who inject drugs: The CDC recommends screening for HIV and hepatitis B and C due to increased risk of transmission.
What to Expect During STI Panel Testing
If you’re wondering how to get tested for STIs, the process is straightforward and typically takes only a few minutes. STI testing is designed to be quick, routine, and as comfortable as possible. You can expect the process to look something like this:
- Order the test: A health care provider orders the STI panel. This can be done through a doctor’s office, clinic, or a direct-access lab service.
- Provide samples: You will give a small blood sample from your arm and provide a urine sample during the same visit. In some cases, swabs may be taken of infected areas. This usually takes about 5 to 15 minutes.
- Send for analysis: Your samples are sent to a CLIA-certified laboratory for testing.
- Get your results: Most results are available within 1 to 5 business days, depending on the tests included.
- Follow up if needed: If any result is positive, a health care provider may recommend confirmatory testing and discuss next steps for treatment.
For guidance on timing your test, including when to get tested after exposure, it’s important to consult a health care provider.
Understanding Your STI Panel Results
STI test results are typically reported using standard terms that indicate whether an infection was detected. If you’re unsure how to read STI results, understanding these categories can help clarify what your results mean:
- Negative / Nonreactive: No evidence of infection was found. However, if testing was done too soon after exposure, the result may not be final due to the STI window period (see table above).
- Positive / Reactive: The test found evidence of an infection. This does not necessarily mean the condition is permanent or untreatable.
- Equivocal / Indeterminate: The result is unclear, and repeat testing is usually needed to confirm the outcome.
In some cases, a positive result must be confirmed with a second test before a diagnosis is made. For example, an initial HIV screening result is typically followed by a confirmatory test. False positives and false negatives can occur, especially if testing is done too early or if additional verification is needed. False results may occur due to improper collection of the sample, timing issues, specific test specificity, interference from medications, recent vaccines, or other health conditions
According to the CDC, many infections identified through STI testing are treatable. Bacterial STIs such as chlamydia, gonorrhea, and syphilis are usually curable with antibiotics, while viral infections like HIV and hepatitis C can be managed with ongoing treatment such as antiviral medications. A health care provider can help interpret your results, recommend next steps, and help you find STD testing near you for follow-up care if needed.